Table of Content
Dermatologicals in Serbia
Euromonitor International
October 2021
List Of Contents And Tables
DERMATOLOGICALS IN SERBIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Stable growth performance as the category avoids strong Coronavirus (COVID-19) impact
Marketing helps to reduce the stigma around the use of dermatologicals
Financial entry barriers push consolidation in dermatologicals
PROSPECTS AND OPPORTUNITIES
Marketing and fading stigma offer positive outlook for dermatologicals
Lilly Drogerie’s expansion could see private label emerge as a significant alternative in the forecast period
Modern retailing development fosters diversity in the distribution of dermatologicals
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2016-2021
Table 2 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 4 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 5 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN SERBIA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources